HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Beta-cell Responsiveness to the Incretin Hormones (Aim1)
This study is now recruiting.
The goal of the study extension is to see whether the incretin hormone GIP increases insulin secretion in individuals with CF and normal glucose tolerance compared to individuals without CF and normal glucose tolerance. This study includes 3 or 4 visits.
Who Do I Contact?
If you are interested in participating in the study or want to learn more please contact our study team at kubrak [at] chop.edu or 267-426-5135.
Eligibility & Criteria
IRB #:
13-010240
Official Title:
Determination of Beta-cell Responsiveness to the Incretin Hormones GLP-1 and GIP in Cystic Fibrosis (Penn IRB of record, # 817585)
Study Phase:
Not Applicable
Eligible Age Range:
18 - 99 Years
Gender:
All
Study Categories:
Leader
